David Greenberg

David Greenberg is an experienced pharmaceutical professional with a robust background in various specialties, including cardiopulmonary and oncology. As the Senior Merz Therapeutics Business Manager since September 2018, David has demonstrated leadership and expertise in the industry. Prior roles include Cardiopulmonary Account Manager at Accredo and Cardiopulmonary Specialist at United Therapeutics. David's career also encompasses work as Oncology and Implant Specialist at Endo International plc and Diagnostics Specialist at Phadia AB. Early experiences include positions at Pfizer Inc. and Pharmacia Corporation. David holds a Bachelor of Arts degree from California State University, Northridge.